GlassScriptPhysician profile
Mary A Hernandez
NPI 1548358724
$876.65
in general payments reported to CMS, 2019-2025
12 companies · $18.73 in 2025
The $18.73 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $367 · 2022: $130 · 2023: $133 · 2024: $229 · 2025: $18.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.29 | 2021-2025 | Jardiance |
| Horizon Therapeutics Plc | $204.98 | 2021-2023 | Krystexxa |
| Ucb, INC. | $123.39 | 2024 | Cimzia |
| Abbvie INC. | $78.56 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $59.87 | 2021 | |
| Janssen Pharmaceuticals, INC | $59.56 | 2022-2024 | Xarelto |
| Biohaven Pharmaceutical Holding Company LTD. | $26.15 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.17 | 2021 | |
| Eisai INC. | $16.07 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.13 | 2024 | Farxiga |
| Arbor Pharmaceuticals, INC. | $13.89 | 2021 | |
| Lilly USA, LLC | $13.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.